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Abstract
Background: Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder associated with a terminal deletion
affecting chromosome 22 (22q13) that results in the loss of function of the SHANK3 gene. SHANK3 has also been
identified in gene-linkage studies to be associated with autism spectrum disorder (ASD). Diagnosis of ASD in individuals
with PMS is complicated by the presence of moderate to profound global developmental delay/intellectual disability as
well as other co-morbid systemic and neurological symptoms.
Methods: The current study aimed to characterize the symptoms of ASD in patients with PMS and to do a preliminary
exploration of genotype-ASD phenotype correlations. We conducted a standardized interview with 40 parents/guardians
of children with PMS. Further, we conducted analyses on the relationship between disruption of SHANK3 and adjacent
genes on specific characteristic symptoms of ASD in PMS in small subset of the sample.
Results: The majority of PMS participants in our sample displayed persistent deficits in Social communication, but only
half met diagnostic criteria under the restricted, repetitive patterns of behavior, interests, or activities domain. Furthermore,
logistic regressions indicated that general developmental delay significantly contributed to the ASD diagnosis. The
analyses relating the PMS genotype to the behavioral phenotype revealed additional complex relationships with
contributions of genes in both deleted and preserved SHANK3 regions to the ASD phenotype and other neurobehavioral
impairments.
Conclusions: There appears to be a unique behavioral phenotype associated with ASD in individuals with PMS. There
also appears to be contributions of genes in both deleted and preserved SHANK3 regions to the ASD phenotype and
other neurobehavioral impairments. Better characterization of the behavioral phenotype using additional standardized
assessments and further analyses exploring the relationship between the PMS genotype and behavioral phenotype in a
larger sample are warranted.
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Background
Autism Spectrum Disorder (ASD) is a behaviorally defined
complex neurodevelopmental disorder. According to the
Diagnostic and Statistical Manual of Mental Disorders
(DSM-5), the core symptoms include qualitative im-
pairments in social communication and the presence
of restricted and repetitive behaviors, interests and ac-
tivities. Though the exact etiology is unknown, recent
studies have identified over 100 genes and recurrent
genomic imbalances implicated in the etiology of ASD
[1]. Though it seems that the genetic contribution to
ASD is complex, accumulating evidence suggests that
the risk genes ultimately converge on a relatively small
set of molecular pathways, including those critical for
synaptic development and plasticity [2]. One such risk
gene is the SH3 and multiple ankyrin repeat domains
3 (SHANK3) gene [3–5], which lies on the distal long
arm of chromosome 22 and whose protein product (by
the same name) acts as a scaffolding protein in its
interactions with various synaptic molecules, including
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the N-methyl-D-aspartate receptor (NMDA-R), class I
metabotropic glutamate receptors (mGluRs), and the
GluR1 a-amino-3-hydroxy-5-methyl–4-isoxazole propionic
acid receptor (AMPA-R) [6]. A recent study reported that a
screen for SHANK3 mutations in 3,833 individuals with
ASD and Intellectual disability (ID) revealed a prevalence of
a mutation in the SHANK3 gene in over 2 % of this group
[7]. Estimates of the prevalence of ASD in patients with
known abnormalities in the region of the SHANK3 gene
(i.e., patients with 22q13 deletion syndrome or Phelan-
McDermid Syndrome (PMS)) are conflicting with pub-
lished studies reporting anywhere from 0–94 % depending
on how the information was obtained [8–10].
Clinical reports of patients with PMS highlight a wide
range of systemic and neurologic manifestations, the
latter including moderate to profound global develop-
mental delay/intellectual disability, hypotonia, absent
or delayed speech, seizures, and decreased perception
of pain [8, 11, 12]. Physical manifestations include minor
dysmorphic features, increased incidence of lymphedema,
cardiac abnormalities, and renal abnormalities [8, 11].
Related to the prevalence of ASD in this population,
their behavior is described as impaired communica-
tion and impaired social interactions with the presence
of self-stimulatory behavior [8].
The aim of this initial study was to systematically
characterize the neurobehavioral profile as it relates to
symptoms of ASD in patients with PMS and to explore
genotype-ASD phenotype correlations. We conducted
a standardized interview with 40 parents/guardians of
children with PMS ages 3–18 that included the Aut-
ism Diagnostic Interview-Revised (ADI-R) [13] and
the Vineland Adaptive Behavior Scale Second Edition
(Vineland II) [14]. Further, in a subgroup of patients, for
whom we had access to DNA data, we were able to con-
duct analyses on the relationship between disruption of
SHANK3 and adjacent genes on specific characteristic
symptoms of ASD in PMS. In addition to examining the
relationship between SHANK3 region deletion, we evalu-
ated the potential contribution of the non-deleted copies
of 22q13 genes that might carry sequence variants modu-
lating SHANK3 protein’s function. Although SHANK3
haploinsufficiency, or epigenetic dysregulation of the gene,
appears to play a major role in determining the ASD
phenotype in PMS, it has been shown that other regions of
22q13 may play a role in the neurobehavioral phenotype of
the syndrome [12, 15, 16]. Thus, it is unclear whether
SHANK3’s loss of function is sufficient for determin-
ing ASD or other genes in the region may also play a
primary or modifying role. Several of the genes in the
SHANK3 region are appealing candidates because of their
demonstrated function: IB2 encodes a scaffold protein
enriched in postsynaptic densities and regulates glutamater-
gic transmission in the cerebellum [17], some genes have
brain-specific expression patterns (IB2, RABL2B), or roles
in SHANK3 regulation (micro-RNA has-mir124910). Based
on the previous literature, we hypothesized that the
children with PMS would show moderate-profound
global developmental delay or intellectual disability and
symptoms consistent with the DSM-5 criteria of ASD.
It was unclear which symptoms would be more severe
or what percent of the sample would meet all of the
diagnostic criteria for ASD. Additionally, DSM-5 criteria
for ASD requires that that the social communication deficit
and other diagnostic impairments must be above what may
be expected based on the individual’s intellectual or com-
munication abilities [18, 19]. Thus, in this population,
and others where there is a global developmental delay,
it is critical that ASD diagnosis be made in the context
of the individual’s general intellectual or communicative
skills. Previous studies in our laboratory have similarly
aimed to characterize the neurobehavioral profile of ASD
in the context of other genetic disorders that often result
in both ASD symptoms as well as global developmental
delay, namely fragile X syndrome and Down syndrome
[20, 21]. Interestingly, previous studies had indicated that
patients with PMS that meet criteria for ASD appear to
have smaller deletions restricted only to the SHANK3
region, while those who did not meet criteria and have a
more severe phenotype had larger deletions that also
affected other genes [8, 16]. This may be a result of smaller
deletions resulting in less severe global delays and thus
more clear demonstration of specific deficits in the social
communication domain. Additionally, no data are available
about the role of the non-deleted SHANK3 region genes.
Thus, the relationship between SHANK3 deficit and ASD
in PMS appears to be quite complex requiring careful
evaluation using standardized, well-validated measures.
Methods
Participants
We recruited a cohort of 40 parents/guardians of children
with PMS in the 3–18 years age range (M= 9.95 years,
SD = 4.46 years; 25 Males, 15 Females). Recruitment was
assisted by the Phelan-McDermid Syndrome Foundation. A
registry of patients with PMS (with a 22q deletion or
SHANK3 mutation) is maintained by the Foundation.
Diagnosis was based on clinical reports supplied by the
parents. Out of the total sample of 40 children: Thirty-one
had deletions affecting the 22q13 region of chromosome
22; Two had complex chromosomal rearrangements in-
cluding a deletion in 22q13 region of chromosome 22;
Three had 22ring chromosomes; One had an unbalanced
translocation involving chromosomes 22 and 18; And One
had a point mutation in 22q13 region of chromosome 22.
Participants self-selected themselves to be part of the
study, based on an announcement that was sent out to all
members of the registry. Enrollment was not biased toward
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whether their diagnosis was a result of a point mutation or
deletion, or the size or exact location of their mutation or
deletion, or whether they showed symptoms of ASD. This
study was reviewed and approved by the Boston Children’s
Hospital Internal Review board, the Committee on Clinical
Investigation.
Procedure
The study involved a single phone interview with at
least one parent/guardian of the affected individual.
The interview consisted of the ADI-R and the Vineland II,
which was administered by a trained psychologist. The
ADI-R is a standardized interview commonly used for
diagnosing autism, planning treatment, and distinguish-
ing autism from other developmental disorders [13]. It
is composed of 93 items, focusing on three functional do-
mains: 1. Language/Communication; 2. Reciprocal Social
Interactions; and 3. Restricted, Repetitive, and Stereotyped
Behaviors and Interests. Interview questions cover eight
content areas: 1) The subject’s background, including
family, education, previous diagnoses, and medications, 2)
Overview of the subject’s behavior, 3) Early development
and developmental milestones, 4) Language acquisition
and loss of language or other skills, 5) Current functioning
in regard to language and communication, 6) Social
development and play, 7) Interests and behaviors, and
8) Clinically relevant behaviors, such as aggression, self-
injury, and possible epileptic features. We re-structured
the ADI-R items and subdomains to align with the new
DSM-5 diagnostic criteria for ASD; one of the authors
(WEK) was a member of DSM-5’s Neurodevelopmental
Disorders Work Group that drafted the revised criteria.
The Vineland II is a leading instrument for supporting
the diagnosis of intellectual disability, particularly
after the DSM-5 revision [14, 19]. The scales of the
Vineland II are organized within a three-domain structure:
Communication, Daily Living, and Socialization. This
structure corresponds to the three broad domains of adap-
tive functioning by the American Association of Intellectual
and Developmental Disabilities: Conceptual, Practical, and
Social. In addition, Vineland II offers a Motor Skills
Domain and an optional Maladaptive Behavior Index to
provide more in-depth information. Both the ADI-R
and Vineland II have good reliability and validity when
administered over the phone [22, 23].
For the 14 patients for whom DNA samples were
available at the Greenwood Genetics Center from a pre-
vious study, we were able to amplify by PCR and screen
by Sanger sequencing the coding regions (including in-
tron/exon boundaries) of the following genes: SHANK3
(22 exons), MAPK8IP2/IB2 (13 exons), RABL2B (8 exons),
hsa-miR-1249 (1 exon). The sequences of the oligonucleo-
tide primers used to sequence the abovementioned genes
are reported in the Additional file 1. The significance of the
findings was evaluated by interrogation of bioinformatic
websites and comparison with genomic variant databases
(see Additional file 1 for websites addresses).
Data analysis
Descriptive and Inferential statistics were computed
based on modified subdomains of the ADI-R based on
DSM-5 criteria and standardized Vineland II scores
using SPSS version 22. The ADI-R was developed to
match the DSM-IV criteria of autism with subdomains
related to A) Qualitative Abnormalities in Reciprocal
Social Interaction (including A1: Failure to use nonverbal
behaviors to regulate social interaction, A2: Failure to
develop peer relationships, A3: Lack of shared enjoyment,
and A4: Lack of socioemotional reciprocity), B) Qualitative
Abnormalities in Communication (including B1: Lack
of or delay in spoken language and failure to compensate
through gesture, B2 (only scored for verbal participants):
Relative failure to initiate or sustain conversational inter-
change, B3 (only scored for verbal participants): Stereo-
typed, repetitive or idiosyncratic speech, and B4: Lack of
varied spontaneous make-believe or social imitative play)
and C) Restricted, Repetitive, and Stereotyped Patterns of
Behavior (including C1: Encompassing preoccupation or
circumscribed pattern of interest, C2: Apparently compul-
sive adherence to nonfunctional routines or rituals, C3:
Stereotyped and repetitive motor mannerisms, and C4:
Preoccupation with parts of objects or nonfunctional ele-
ments of material).
In order to fit with current DSM-5 criteria, the subdo-
mains were reclassified as A) Persistent deficits in social
communication and social interaction across multiple con-
texts including A1: Deficits in social-emotional reciprocity,
which included the domains previously categorized under
A4 (and B2 for verbal participants), A2: Deficits in nonver-
bal communicative behaviors used for social interaction,
which included the domains previously categorized under
A1 and B1, A3: Deficits in developing, maintaining, and
understanding relationships, which included the domains
previously categorized under A2 and B4, B) Restricted,
repetitive patterns of behavior, interests, or activities
(including B1: Stereotyped or repetitive motor movements,
use of objects, or speech, which included domains previ-
ously categorized under C3 (and B3 for verbal participants),
B2: Insistence on sameness, inflexible adherence to rou-
tines, or ritualized patterns or verbal nonverbal behavior,
which matched to C2 in the ADI-R, B3: Highly restricted,
fixated interests that are abnormal in intensity or focus,
which matched to C1 in the ADI-R, and B4: Hyper- or
hyporeactivity to sensory input or unusual interests in
sensory aspects of the environment, which matched to
C4 in the ADI-R. Averages per question scores were
calculated to evaluate the degree of impairment in
each of these reclassified domains. On the ADI-R each
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question is scored on a three-point scale with 0 indi-
cating no impairment, 1 indicating some impairment,
and 2 indicating significant impairment related to that
specific behavior.
Logistic regression analyses were conducted on factors
that contribute to the presence or absence of an ASD
diagnosis, as it has been done previously in our laboratory
to characterize the neurobehavioral profile of ASD in the
context of other genetic disorders including fragile X
syndrome and Down syndrome [20, 21]. Descriptive
analyses as well as Pearson product mean correlation
coefficients were calculated on the genetic analyses as
well as the relationships between the genetic analyses
and the behavioral phenotype.
Results
Behavioral results
Group Average Vineland II standard scores (age norm 100)
ranged from 48 (Communication subdomain score) to 60
(Motor subdomain score) with only one individual scoring
in the average range (Fig. 1). None of the individuals appear
to have spared or splinter skills, which together with the
Vineland II scores suggest a global cognitive deficit (i.e.,
global developmental delay or intellectual disability). Most
individuals (75 %) were nonverbal and 21 subjects (53 %)
had a clinical diagnosis of ASD. Based on the ADI-R, the
overwhelming majority of the sample (90 %) displayed per-
sistent deficits in Social communication, the first DSM-5
diagnostic criteria for ASD.However, only approximately
half of the sample (55 %) met diagnostic criteria for
Restricted, repetitive patterns of behavior, interests, or
activities (presence of symptoms in two domains), the
second DSM-5 diagnostic criteria for ASD. Commonly
seen in this sample were hyper- or hyporeactivity to
sensory input or unusual interests in sensory aspects
of the environment (DSM5-B4). This manifested as
chewing behavior in 68 % of the sample and is consistent
with previous reports of individuals with PMS [11]. A
large proportion of the sample also had blunted facial
expression, present in 73 % of participants. PMS subjects’
Fig. 1 Standard scores for the Vineland II Communication, Living Skills, Social, and Motor domains. 50th percentile in the general population is
100. Average Scores reflect mild to moderate impairments in adaptive skills in patients with PMS. Blue Bars represent the entire dataset, red bars
represent the subgroup who we identified to carry SHANK3 Variants green bars represent the subgroup who were confirmed not to carry a
SHANK3 Variant. Error Bars represent the Standard Error of the Mean
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emotional facial expressions appear to be limited with a
bias toward a happy expression. A history of epilepsy was
present in 20 % of the sample. Loss of social communica-
tion skills was only observed in a single participant with
no relationship with onset of seizures or other medical
conditions, suggesting that regression is not common in
the study population (Table 1).
For all participants, an analysis of variance (ANOVA)
was conducted on the seven subdomains of diagnostic
criteria: A) Persistent deficits in social communication and
social interaction across multiple contexts (including A1:
Deficits in social-emotional reciprocity, A2: Deficits in non-
verbal communicative behaviors used for social interaction,
A3: Deficits in developing, maintaining, and understanding
relationships), B) Restricted, repetitive patterns of behavior,
interests, or activities (including B1: Stereotyped or repe-
titive motor movements, use of objects, or speech, B2: In-
sistence on sameness, inflexible adherence to routines, or
ritualized patterns or verbal nonverbal behavior, B3: Highly
restricted, fixated interests that are abnormal in intensity or
focus, and B4: Hyper- or hyporeactivity to sensory input or
unusual interests in sensory aspects of the environment).
The ANOVA revealed a significant difference in degree of
impairment across subdomains (F (6,234) = 52.244, p <
0.001) with the greatest impairment shown in DSM-5
Social communication and specifically Nonverbal commu-
nication used for social interaction (A2) (M= 1.45, SD =
0.49) and the least impairment shown in DSM-5 Restricted,
repetitive behavior, interests or activities and specifically
Insistence on sameness, inflexible adherence to routines, or
ritualized patterns or verbal nonverbal behavior (B2)
(M = 0.25, SD = 0.41) (Fig. 2).
A forward stepwise linear regression analysis was
conducted in order to determine whether the persistent
deficits in social communication could be accounted for by
the overall developmental delay/intellectual impairment
indicated by the Vineland II subdomain scores. The only
score that significantly predicted the ADI-R Social
communication domain score was the Vineland II So-
cial subdomain score (Adjusted R2 = 0.39, β = −0.635,
p < 0.001). A forward stepwise logistic regression analysis
was conducted to determine which ADI-R or Vineland II
scores significantly contributed to the presence or absence
of a clinical ASD diagnosis. A test of the full model versus
a model with the intercept only was statistically signifi-
cant, χ2 (6, N = 40) = 14.13, p < 0.05 Negelkerke R2 = 0.397.
The model was able to correctly classify 74 % of those
who do not have ASD and 86 % of those who do, for an
overall success rate of 80 %. Employing a 0.05 threshold
for statistical significance, only the Vineland II Social
subdomain score significantly contributed to the model
(b = −0.236, Wald χ2 (1) = 7.123, p < 0.01).
Genotype-phenotype relationships
Of the 40 individuals in the study, DNA samples were
available for 14 (Mean Age = 11.69, SD 4.23). The aver-
age size of the deletion in these individuals was 5.01 MB
(SD = 2.45) (range = 0.22–9.18). This subgroup had a
similar behavioral profile as the larger group with 8/14
(57 %) having an clinical diagnosis of ASD and 64 %
who were nonverbal. The ADI-R scores reflected persist-
ent deficits in Social communication in 79 % and pres-
ence of Restricted, repetitive patterns of behavior,
interests, or activities in two domains in 43 % of individ-
uals in this subgroup. The Vineland II scores also matched
the larger group with average subdomain standard scores
ranging from 48 (Communication subdomain score) to 59
(Motor subdomain score).
Pearson Correlation Coefficients were calculated to
evaluate the association between size of deletion and
behavioral phenotype. Significant associations and trends
were observed for both the ADI-R and Vineland II scores:
ADI-R DSM-5 Restricted, repetitive patterns of behavior,
interests, or activities was negatively correlated with size of
deletion (r(14) = −0.48, p = 0.09); Vineland II Communica-
tion subscore (r(14) = −0.57, p = 0.03); Vineland II Motor
subscore (r(14) = −0.68, p < 0.01) and Vineland II Living
Skills subscore (r(14) = −0.51, p = 0.06) were also negatively
correlated. Note that all relationships were negative, indi-
cating more severe restricted and repetitive behavior was
associated with a smaller deletion size but larger genetic
loss with more impaired general adaptive behavior skills.
Also note that neither the Social Communication sub-
score on the ADI-R nor the Social subdomain on the
Vineland II significantly correlated with deletion size.
A second set of analyses, illustrated in Table 2, examined
the allelic non-deleted SHANK3 region for a possible “sec-
ond hit” phenomenon. Nine out of fourteen individuals
displayed variants that have been previously associated with
ASD. Eight out of fourteen subjects (57 %) carried the
Table 1 Sample characteristics (N = 40)
Sample characteristic N Percentage
Gender (Male:Female) 25:15 62.5 %:37.5 %
Clinical ASD Dx (Parent Report) 21 52.5 %
Language (Verbal: Nonverbal) (ADI-R) 10:30 25 %:75 %
Social Communication Deficit (ADI-R) 36 90 %
Restricted and Repetitive Behavior, Interests
and Activities (ADI-R)
22 55 %
Sensory Seeking Activities (ADI-R) 27 68 %
Epilepsy (Parent Report) 8 20 %
Blunted Facial Expression (ADI-R) 29 73 %
True Regression (ADI-R) 1 2.5 %
Borderline Adaptive Behavior Delay (Vineland II) 2 5 %
Mild Adaptive Behavior Delay (Vineland II) 21 52.5 %
Moderate Adaptive Behavior Delay (Vineland II) 17 42.5 %
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SHANK3 c.1612 + 18C >T substitution in intron 13, which
is predicted to cause abnormal splicing. One additional
participant carried the SHANK3 c.1304 + 48C >T substitu-
tion in intron 10, which removes a CpG island in one of
the four intragenic regulatory elements and has been re-
ported to be associated with ASD [5]. The group with the
SHANK3 variants had more severe social communication
deficits and more impaired adaptive skills, as compared
to the remaining six patients not carrying the change,
though these differences failed to reach significance.
Analysis of other genes in the SHANK3 region was re-
stricted to profiling one subject with the IB2 c.595G >A
substitution in intron 13, not previously described in any
variant database. This individual also carried the SHANK3
c.1612 + 18C >T substitution and displayed significantly
less severe social communication deficits on the ADI-R,
but significantly more severe impairments in adaptive be-
havior skills on the Vineland II (all ps <0.01).
Discussion
The goal of the current study was to perform an initial
characterization of the ASD behavioral phenotype, and
its genotypical correlations, in individuals with PMS.
The results indicate that the subjects in our sample had a
complex behavioral phenotype, most notably characterized
as mild to moderate generalized developmental delay/intel-
lectual disability. As it relates to autism specific symptoms,
the majority of the individuals displayed persistent deficits
in Social communication, but only half met diagnostic cri-
teria under the Restricted, repetitive patterns of behavior,
interests, or activities domain. In the context of the general
delay/deficit in adaptive behavior shown in this population,
it is imperative to recognize that the DSM-5 is more ex-
plicit in that the social communication deficit and other
diagnostic impairments must be above what may be ex-
pected based on the individual’s intellectual or communica-
tion abilities [18, 19]. This is especially critical as logistic
Fig. 2 Average per question scores on the ADI-R subdomains that index the core symptoms of ASD based on the DSM5 criteria. A score of zero indicates
no evidence of symptoms in that subdomain, a score of one indicates some evidence of symptoms in that subdomain, a score of two indicates definite
evidence of symptoms in that subdomain. Patients in this sample display evidence of symptoms in the Social Communication domain, but relatively fewer
symptoms in the Restricted and Repetitive Behavior (RRB) domain. Dashed lines indicate the mean values for the subgroup who we identified to carry
SHANK3 Variants. Dotted lines indicate the mean values for the subgroup who were confirmed not to carry a SHANK3 Variant. Error Bars represent the
Standard Error of the Mean
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regressions indicated that the main factor that contributed
to the clinical diagnosis of ASD was the Social subdomain
from the Vineland II, rather than any factor from the ADI-
R. Thus, additional testing will need to be conducted in
order to evaluate what proportion, for instance, of the social
communication deficits are accounted for by the general
developmental delay in each individual.
Some suggested measures would include a standard-
ized IQ assessment such as the Stanford-Binet, Fifth
Edition (SB5). Other standardized measures such as the
Peabody Picture Vocabulary Test and the Expressive
Vocabulary Test could be used to quantify the degree of
impairment in receptive and expressive language skills.
The Autism Diagnostic Observation Schedule, Second
Edition (ADOS-2) combined with the ADI-R is consid-
ered the gold-standard for ASD diagnosis, thus, when
feasible, ASD diagnosis should incorporate the ADOS-2.
Another standardized assessment found to identify sa-
lient non-diagnostic, but associated features of ASD is
the Aberrant Behavior Checklist (ABC). The ABC Irrit-
ability subscale would be specifically interesting in light of
the observation in this sample that despite having signi-
ficant social communication deficits including limited
emotional facial expression, participants generally had a
happy demeanor.
The analyses relating the PMS genotype to the behav-
ioral phenotype revealed additional complex relationships.
Consistent with other reports, there appeared to be a
trend toward a negative relationship between size of dele-
tions and the presence of repetitive and restricted patterns
of behavior, interests and activities with smaller deletions
leading to more severe phenotype [8, 16] while deletion
size was not significantly associated with Social Commu-
nication deficits. These data suggest that specific gene def-
icits but not total loss of genetic material may explain
ASD in PMS. An inverse correlation was also found be-
tween deletion size and adaptive communication, motor
and living skills indicating that, nonetheless, magnitude of
gene loss matters since larger deletions were associated
with greater adaptive skill impairment. Considering that
our cohort had marked impairment in adaptive communi-
cation (Table 1) and that these skills are highly correlated
with overall cognitive function in autistic and non-autistic
individuals [24, 25], our data suggest that general develop-
mental delay may have masked the contribution of other
genes in the deleted SHANK3 region to ASD symptoms.
A novel aspect of the present study is the examination of
the role of the preserved SHANK3 region in the PMS
phenotype. For the first time, the hypothesis of a “second
hit” model involving 22q13 genes has been tested. The se-
lected genes have brain-specific expression and are in-
volved in synaptic function and neuronal development.
The rationale behind our analysis was based on the possi-
bility that sequence variants, even if not clearly
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deleterious, could affect the function of the preserved
copy of those genes, modulating the neurobehavioral
phenotype of the subject and contributing to the hetero-
geneity in the clinical presentation of PMS. Although pre-
liminary, the association of the SHANK3 c.1304 + 48C > T
and SHANK3 c.1612 + 18C > T variants with greater defi-
cits in social communication and adaptive skills compared
to those without these variants support a “second hit”
phenomenon. Moreover, the observation of one subject
with both the IB2 c.595G > A variant and SHANK3 c.1612
+ 18C > T variant with milder social communication im-
pairments, but more severe adaptive behavior skills, em-
phasizes the need for directly examining other genes in
the SHANK3 region in both deleted and preserved
chromosome 22. Overall, 9 out of 14 subjects (64.3 %)
presented at least one variant with potential effects on the
protein function (Table 2), suggesting that 22q13 deletions
may in some cases unmask rare autosomal recessive gene
deficits and that the genetic contribution to the PMS
phenotypical heterogeneity should be investigated beyond
the mere haploinsufficiency.
The present study should be considered as preliminary in
nature, providing directions for future investigations of the
ASD phenotype and its genetic bases in PMS. Among its
most important contributions are the use of standardized
behavioral measures and the DSM-5 diagnostic approach
to ASD. To our knowledge, the subject sample is the
largest reported in behavioral studies of PMS. Never-
theless, the behavioral characterization was limited by
relying on only two instruments and exclusively on
interviews. Direct assessment and use of a comprehen-
sive neurobehavioral battery described above are essen-
tial follow up steps, which we intend to pursue with the
same cohort. The second highlight of this study is the
analysis of genetic contributions beyond deletion size.
The inclusion of the non-deleted SHANK3 region was a
revealing and promising line of inquiry. The genotype-
phenotype correlations here underscore the complexity
of examining the role of deleted genetic material and
the need of having a more complete picture of the
neurobehavioral phenotype. For instance, we could not
rule out that magnitude of genetic loss does indeed have an
impact on ASD severity because of the co-existence of
severe adaptive behavior impairment. The relatively small
subset of subjects with genotype data was an important
limitation considering that our findings suggest the need
for complex statistical models, which incorporate genes in
both deleted and preserved SHANK3 regions. Our future
correlative studies will address the shortcomings discussed
here.
Conclusions
In summary, there appears to be a unique behavioral
phenotype associated with ASD in individuals with PMS
that warrants further investigation. Careful neuropsycho-
logical evaluations are necessary to ensure that the social
communication deficits present in these individuals cannot
be explained by their overall developmental delay/inte-
llectual disability. These additional standardized measures
assessing social communication and intellectual functioning
will further validate the diagnosis of ASD in individuals
with PMS. There also appear to be contributions of genes
in both deleted and preserved SHANK3 regions to the ASD
phenotype and other neurobehavioral impairments, which
need a more detailed examination with a larger sample.
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